highperformr logo

A. Menarini GmbH's Overview

Total employees288
HeadquartersBerlin
Founded1996

A. Menarini GmbH is the German subsidiary of the Menarini Group, an Italian multinational pharmaceutical and diagnostics company. Operating primarily from Berlin, A. Menarini GmbH focuses on the marketing, sales, and distribution of a wide range of pharmaceutical products in Germany across various therapeutic areas. These often include cardiology, oncology, pain/inflammation, asthma/COPD, and diabetes. The company is committed to providing innovative healthcare solutions and high-quality medicines to patients and healthcare professionals in the German market, leveraging the research and development capabilities of the broader Menarini Group.

Where is A. Menarini GmbH's Headquarters?

HQ Function

Serves as the primary hub for Menarini's commercial operations in Germany, including sales, marketing, medical affairs, regulatory activities, and distribution management for the German market.

Notable Features:

Modern office complex designed to facilitate collaboration and efficient operations. As part of the larger Berlin-Chemie campus, it benefits from proximity to research, production, and logistics facilities, though A. Menarini GmbH itself is primarily focused on commercial activities.

Work Culture:

The work culture likely combines German efficiency and structured processes with the patient-centric and innovative focus of the Menarini Group. Emphasis is placed on professionalism, teamwork, and contributing to healthcare advancements.

HQ Significance:

The Berlin headquarters is strategically important for accessing and serving the German pharmaceutical market, one of the largest and most influential in Europe. It enables direct engagement with German healthcare stakeholders.

Values Reflected in HQ: The headquarters' operations reflect Menarini's commitment to quality, scientific rigor, ethical conduct, and dedication to patient health in the German context.

Location:

A. Menarini GmbH is a key component of the Menarini Group's extensive international network. The Menarini Group operates in over 140 countries worldwide through its own subsidiaries, including A. Menarini GmbH in Germany, and partnerships. Globally, the Group supports functions like pharmaceutical research and development, drug manufacturing, quality assurance, marketing, sales, and distribution across diverse therapeutic areas such as cardiovascular diseases, oncology, pain management, respiratory illnesses, and metabolic disorders.

Street Address:

Glienicker Weg 125

City:

Berlin

State/Province:

Berlin

Country:

Germany

A. Menarini GmbH's Global Presence

Großbeeren, Brandenburg/Germany

Address: Märkische Allee 69, 14979 Großbeeren (Berlin-Chemie AG Logistics Center)

Ensures efficient warehousing, packaging, and distribution of pharmaceutical products, supporting the commercial activities managed from the Berlin headquarters.

Florence, Italy (Global HQ of Menarini Group)

Address: Via dei Sette Santi 3, 50131 Florence, Italy

Central hub for global governance, R&D pipeline management, and corporate functions supporting all subsidiaries, including A. Menarini GmbH.

Buying Intent Signals for A. Menarini GmbH

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of A. Menarini GmbH

As of April 2025, A. Menarini GmbH' leadership includes:

Dr. Reinhard Miemietz - Geschäftsführer (Managing Director), A. Menarini Research & Business Service GmbH
Dr. Steffen Salomo - Geschäftsführer (Managing Director), A. Menarini Research & Business Service GmbH
Michael Sirotovitch - Former CEO, Berlin-Chemie AG (Key German entity of Menarini Group, closely associated with A. Menarini GmbH operations)
Dr. Marion Blumberg - Member of the Board, Berlin-Chemie AG
Elcin Ergun - Chief Executive Officer, Menarini Group (Oversees global operations including Germany)

Investors of A. Menarini GmbH

A. Menarini GmbH has been backed by several prominent investors over the years, including:

The Menarini Group (Parent Company, privately owned by the Aleotti family)

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

Specific executive changes for A. Menarini GmbH are not always widely publicized. However, leadership roles within the broader Berlin-Chemie AG or Menarini Group impacting German operations may be announced. No major, widely publicized C-suite changes specifically for 'A. Menarini GmbH' were identified in the immediate past 12 months. Changes are typically announced via official company channels.

Technology (Tech Stack) used by A. Menarini GmbH

Discover the tools A. Menarini GmbH uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

A. Menarini GmbH Email Formats and Examples

A. Menarini GmbH, as part of the Menarini Group and its German entity Berlin-Chemie, likely utilizes email formats common within the group. These typically involve combinations of the employee's first and last name with the company domain.

Common formats include [first_initial][lastname]@berlin-chemie.de (e.g., jdoe@berlin-chemie.de) or [firstname].[lastname]@berlin-chemie.de (e.g., jane.doe@berlin-chemie.de). The global @menarini.com domain might also be used by some executives or for international correspondence.

Format

m.mustermann@berlin-chemie.de

Example

80%

Success rate

News and media

Menarini Group WebsiteFebruary 13, 2024

Menarini Group Announces Positive Top-Line Results from Phase 3 EMERALD Study in Asia

The Menarini Group announced positive top-line results from the Phase 3 EMERALD clinical trial evaluating elacestrant in ER+, HER2- metastatic breast cancer patients in Japan, South Korea, and Taiwan. This demonstrates ongoing commitment to oncology R&D globally....more

berlin-chemie.deNovember 20, 2023

Berlin-Chemie (Menarini Germany) Reports Positive Outcome from Diabetes Autumn Conference 2023

Berlin-Chemie, part of the Menarini Group, shared positive results and insights from its participation in the Diabetes Autumn Conference 2023, highlighting its commitment to diabetes care and new therapeutic approaches in Germany....more

Menarini Group WebsiteOctober 26, 2023

Menarini Group and Insilico Medicine Announce Global Licensing Agreement for Novel KAT6A Inhibitor

The Menarini Group entered into an exclusive global licensing agreement with Insilico Medicine for the development and commercialization of a novel small molecule inhibitor of KAT6A for treating ER+/HER2- breast cancer. Menarini will lead clinical development and commercialization, impacting its oncology portfolio available through subsidiaries like A. Menarini GmbH....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including A. Menarini GmbH, are just a search away.